Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | 27,000 | reported | 12 Jun 2025 | tx 5+88,633 |
| Editas Medicine, Inc. | 25,000 | reported | 30 May 2024 | tx 5+109,614 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Editas Medicine, Inc. | 25,000 | 0.00 USD | deriv |
| 24 May 2024 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 13,200 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Editas Medicine, Inc. | 25,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Editas Medicine, Inc. | 25,000 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 7,733 | 0.00 USD | deriv |
| 28 Oct 2021 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 23,200 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | Editas Medicine, Inc. | 11,538 | 0.00 USD | deriv |
| 17 Dec 2020 | GRANT_AWARD | Editas Medicine, Inc. | 23,076 | 0.00 USD | deriv |